FitLife Brands (FTLF) Stock Price, News & Analysis

Company Overview

FitLife Brands, Inc. provides nutritional supplements for health-conscious consumers in the United States and internationally. The company provides weight loss, sports nutrition, and general health products; sports nutrition products; weight loss and sports nutrition products; sports nutrition and general wellness formulations with an emphasis on natural, vegan, and organic ingredients; and male health and weight loss products, as well as other diet, health, and sports nutrition supplements and related products; and value-oriented sports nutrition and weight loss products. It offers MRC products which includes general health supplements; and natural skincare and beauty products. In addition, it markets its products under the brand names of NDS Nutrition, PMD Sports, SirenLabs, CoreActive, Nutrology, Metis Nutrition, iSatori, BioGenetic Laboratories, Energize, Dr. Tobias, All-Natural Advice, and Maritime Naturals through franchised stores, as well as through retail locations, which include specialty, mass, and online. The company was formerly known as Bond Laboratories, Inc. and changed its name to FitLife Brands, Inc. in September 2013. FitLife Brands, Inc. was incorporated in 2005 and is headquartered in Omaha, Nebraska.

Key Stats

• Today's Range: $9.54 to $10.07
• 50-Day Range: $8.88 to $14.28
• 52-Week Range: $8.67 to $20.98
• Volume: 29,016 shs
• Average Volume: 24,961 shs
• Market Capitalization: $91.74 million
• P/E Ratio: 16.18
• Dividend Yield: N/A
• Price Target: $21.50
• Consensus Rating: Hold

FitLife Brands Stock Analysis - MarketRank™

FitLife Brands scored higher than 89% of companies evaluated by MarketBeat, and ranked 70th out of 865 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Hold

Consensus Rating

FitLife Brands has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on no strong buy ratings, 2 buy ratings, 1 hold rating, and 1 sell rating.

Upside Potential

FitLife Brands has a consensus price target of $21.50, representing about 119.4% upside from its current price of $9.80.

Amount of Analyst Coverage

FitLife Brands has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 3.1 / 5
• Proj. Earnings Growth: 38.55%

Earnings Growth

Earnings for FitLife Brands are expected to grow by 38.55% in the coming year, from $0.83 to $1.15 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of FitLife Brands is 16.23, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.56.

Price to Earnings Ratio vs. Sector

The P/E ratio of FitLife Brands is 16.23, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 21.07.

Price to Book Value per Share Ratio

FitLife Brands has a P/B Ratio of 2.11. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

5.17% of the float of FitLife Brands has been sold short.

Short Interest Ratio / Days to Cover

FitLife Brands has a short interest ratio ("days to cover") of 5.71.

Change versus previous month

Short interest in FitLife Brands has recently increased by 14.17%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

FitLife Brands does not currently pay a dividend.

Dividend Growth

FitLife Brands does not have a long track record of dividend growth.

News and Social Media

• Score: 3.0 / 5
• News Sentiment: 0.87

News Sentiment

FitLife Brands has a news sentiment score of 0.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for FitLife Brands this week, compared to 2 articles on an average week.

Search Interest

Only 1 people have searched for FTLF on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.

MarketBeat Follows

1 people have added FitLife Brands to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 4.3 / 5
• Insider Trading: Acquiring Shares

Cluster Insider Buying

2 insiders have purchased shares of FitLife Brands in the last three months. Multiple insiders buying is a strong bullish signal.

Net Insider Buying

Over the last three months, insiders have purchased a net $59,220.00 in company stock, which represents 0.0644% of the company's market cap.

Insider Buying vs. Insider Selling

In the past three months, FitLife Brands insiders have bought more of their company's stock than they have sold. Specifically, they have bought $59,220.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

61.40% of the stock of FitLife Brands is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

2.32% of the stock of FitLife Brands is held by institutions.

Company Calendar

• Last Earnings: 5/14/2026
• Today: 6/03/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:FTLF
• CIK: 1374328
• Web: www.fitlifebrands.com
• Phone: 402-991-5618
• Fax: N/A
• Employees: 20
• Year Founded: 2005

Price Target and Rating

• Average Price Target for FitLife Brands: $21.50
• High Price Target: $25.00
• Low Price Target: $18.00
• Potential Upside/Downside: +117.0%
• Consensus Rating: Hold
• Rating Score (0-4): 2.25
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.60
• Trailing P/E Ratio: 16.41
• Forward P/E Ratio: 11.94
• P/E Growth: N/A
• Net Income: $6.33 million
• Net Margins: 6.64%
• Pretax Margin: 8.65%
• Return on Equity: 18.31%
• Return on Assets: 8.21%

Debt

• Debt-to-Equity Ratio: 0.78
• Current Ratio: 1.52
• Quick Ratio: 0.49

Sales & Book Value

• Annual Sales: $81.46 million
• Price / Sales: 1.14
• Cash Flow: $1.17 per share
• Price / Cash Flow: 8.50
• Book Value: $4.65 per share
• Price / Book: 2.13

Miscellaneous

• Outstanding Shares: 9,390,000
• Free Float: 3,625,000
• Market Cap: $93.05 million
• Optionable: Not Optionable
• Beta: 0.02